Sort
78,016 grants matching “breast cancer”
Medical University of South Carolina - Cancer Center Support Grant
$2,156,301Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2023 · CA
Medical University of South Carolina - Cancer Center Support Grant
$2,156,301Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2022 · CA
Pharmacogenetics in Rural and Underserved Populations
$2,156,000Kenneth E. Thummel · University Of Washington · U01 · FY2010 · GM
Risk Factors for Breast Cancer in Younger Nurses
$2,155,604Walter C. Willett · Harvard School Of Public Health · R01 · FY2010 · CA
Combating Subclonal Evolution of Resistant Cancer Phenotypes
$2,154,776Andrea Hope Bild · Beckman Research Institute/City Of Hope · U54 · FY2018 · CA
Cancer Risk in Human Populations
$2,153,446Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Pharmacogenetics Research Network and Knowledge Base
$2,153,438David Alastair Flockhart · Indiana University Indianapolis · U01 · FY2008 · GM
SPORE in Breast Cancer
$2,153,378Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2021 · CA
BREAST& CERVICAL CANCER EARLY DETECTION PROG- WOMEN'S HLTH CHECK COMPREHENSIVE CA
$2,151,989Dieuwke Spencer · Idaho State Dept Of Health And Welfare · U58 · FY2010 · DP
Seattle Cancer Consortium Breast SPORE
$2,150,779Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2014 · CA
Mayo Clinic SPORE in Ovarian Cancer
$2,150,500Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2013 · CA
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,150,500Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2013 · CA
Mayo Clinic Breast Cancer SPORE
$2,150,500Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2013 · CA
SPORE in Breast Cancer
$2,150,500Carlos L Arteaga · Vanderbilt University · P50 · FY2013 · CA
Targeted antigen receptor treatment of cancer
$2,150,453Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,149,233Peter Karl Sorger · Harvard Medical School · U54 · FY2020 · CA
CIS Research Consortium (CISRC): Years 2006-2011
$2,148,228Alfred C Marcus · University Of Colorado Denver · P01 · FY2006 · CA
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$2,148,164Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,147,606Peter Karl Sorger · Harvard Medical School · U54 · FY2018 · CA
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
$2,147,232Lawrence H Kushi · Kaiser Foundation Research Institute · P01 · FY2020 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$2,147,209Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Cell Migration in 3D microenvironments
$2,145,114Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Center for Pre-Clinical Cancer Research
$2,144,025Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM
CANCER CENTER SUPPORT GRANT
$2,143,630City Of Hope/Beckman Research Institute · P30 · FY2000 · CA
Washington University SPORE in Pancreatic Cancer
$2,143,077William G Hawkins · Washington University · P50 · FY2017 · CA